|
Prevalence (%) of clinical parameters based on data from 1 references describing 7 individuals
Add new symptom/sign to this disease
List of symptoms
Symptom/sign |
Organ system |
Percent affected |
Pubmed id |
Added on(yyyy-mm-dd) |
Edit/add reference |
Cerebellar atrophy |
nervous |
86 % |
22522420 |
2024-05-28 |
|
Increased blood CK |
circulatory |
57 % |
22522420 |
2024-05-17 |
|
Cataract |
nervous |
57 % |
22522420 |
2024-05-17 |
|
Corpus callosum thining |
nervous |
43 % |
22522420 |
2024-05-17 |
|
Brainstem hypoplasia |
nervous |
43 % |
22522420 |
2024-05-17 |
|
Microphthalmia |
nervous |
43 % |
22522420 |
2024-05-17 |
|
Heterotopia |
nervous |
29 % |
22522420 |
2024-05-17 |
|
White matter hyperintensities |
nervous |
29 % |
22522420 |
2024-05-17 |
|
Pachygyria |
nervous |
29 % |
22522420 |
2024-05-17 |
|
Optic nerve atrophy |
nervous |
29 % |
22522420 |
2024-05-17 |
|
Muscle atrophy |
skeletal |
29 % |
22522420 |
2024-05-17 |
|
Abnormal cornea |
nervous |
14 % |
22522420 |
2024-05-17 |
|
Retinal dysplasias |
nervous |
14 % |
22522420 |
2024-05-17 |
|
Thinning of cerebral gray matter |
nervous |
14 % |
22522420 |
2024-05-17 |
|
Macular degeneration |
nervous |
14 % |
22522420 |
2024-05-17 |
|
Brainstem atrophy |
nervous |
14 % |
22522420 |
2024-05-17 |
|
List of references:
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Tobias Willer, Hane Lee, Mark Lommel, Takako Yoshida-Moriguchi, Daniel Beltran Valero de Bernabe, David Venzke, Sebahattin Cirak, Harry Schachter, Jiri Vajsar, Thomas Voit, Francesco Muntoni, Andrea S Loder, William B Dobyns, Thomas L Winder, Sabine Strahl, Katherine D Mathews, Stanley F Nelson, Steven A Moore, Kevin P Campbell,
Nature genetics - May 2012
|